TB is the biggest killer among infectious diseases globally. The UK is already leading the way to tackle TB through investment in research and development. UK aid will help develop three new TB drugs, which offer quicker-acting treatments for the millions of people affected by drug-resistant TB each year. The work of our expert scientists is bolstering our efforts to ensure we can tackle these diseases that do not respect borders. It is a win for the UK and a win for the developing world. This is a new exciting era for TB diagnostics. These advances will soon mean those suffering with TB can get individual treatment that is right for them to help them fight the disease, moving beyond treating patients on a “best guess” basis. If you have an urgent media query, please email the DFID Media Team on [email protected] in the first instance and we will respond as soon as possible. Telephone 020 7023 0600 £7.5 million new UK aid support has been given to the TB Alliance to develop shorter, simpler treatments against TB that are affordable to the poorest countries in the world. The latest figures on TB published by the World Health Organization show that in 2017, 10 million people developed this preventable and treatable disease and 1.6 million people died. Through our support to the Global Fund in the fourth replenishment round (2014-2016) the UK ensured TB treatment was provided to 1.26m people worldwide. The UK supports the Foundation for Innovative New Diagnostics, which is developing new diagnostic tests for TB. Funding to date has included support for the highly successful GeneXpert test, which is now used in 140 countries, including the UK, to help improve diagnosis for TB. General media queries (24 hours) International Development Secretary Penny Mordaunt announced at the UN General Assembly yesterday (Wednesday 26 September) that UK aid will be dedicated to developing shorter, safer and more effective treatments for TB.These new treatments could also help tackle the rise of drug resistant TB. In 2017 an estimated 600,000 people developed drug resistant TB but the success rate with current treatments is 55 per cent – making it a major public health crisis.Scientists and health workers in developing countries are constantly battling to combat this leading killer infectious disease, with mortality rates being higher in low income countries such as Mozambique and the Central African Republic.This latest support for the TB Alliance will help develop new, safer drugs for the disease, which last year infected 10 million people.Speaking after a high-level meeting on TB at UNGA yesterday Ms Mordaunt said: Email [email protected] The UK government has been clear this research alone is not enough to meet the Global Goal target to end TB by 2030. That is why Heads of State will meet at the high-level meeting at UNGA to sign a political declaration, signalling a step-change in the international leadership and commitments necessary to drive progress on fighting TB.DFID has also supported Aeras, a non-profit organisation working with GSK and other partners, to develop and test a new TB vaccine. Early results show the number of HIV-negative people developing TB was reduced by about half.The UK already provides substantial support to international organisations, including the Global Fund, Unitaid and world-class research to develop new health products. These investments support large-scale TB programmes and critical research into innovative new medicines and diagnostics to help tackle TB. The UK’s work in strengthening country health systems also plays a vital role in tackling the disease.Yesterday the University of Oxford also announced its team of scientists and global experts have led a major breakthrough in the understanding of TB’s genetic code. Their research has the potential to shape how TB is diagnosed in the future to make sure the right drugs are prescribed.Dr Timothy Walker, Academic Clinical Lecturer in Infectious Diseases and Microbiology at the University of Oxford, said: Public Health England announced this week TB rates in England have dropped to the lowest level since 1990. The data showed a 38 per cent drop in new diagnoses from the peak in 2011 to 2017 (from 8,280 to 5,102).Notes to editors
Targeting desperate peopleCredit-repair companies target people who desperately want a car,a house, insurance or even a job but have bad credit. Thesepeople are lured by ads claiming, “We can erase your bad credit– 100-percent guaranteed.”They wrongly claim they can erase information from your creditreport.If you feel you need to seek repair for your bad credit, keep inmind: By Michael RupuredUniversity of GeorgiaOnly serious effort, time and a good debt-repayment plan can helprepair bad credit. Unfortunately, many companies want people tobelieve otherwise. These companies make false claims about credit repair. Peoplebelieve these claims, pay the companies money and find themselveswith the same bad credit.In many cases, the credit-repair company may encourage you tocommit a crime by asking you to create a federal ID number.Basically, they’re asking you to create a new identity, which isillegal. Credit-repair companies are not allowed to make false claimsabout their services.They can’t charge you until services are complete.They can’t perform any services until they have your signatureand have completed a three-day waiting period.Inaccurate information can be removed at no cost by reportingthe error to the credit-reporting agency.It’s illegal to create a new identity to get credit.Sometimes self-help may be the best option. There is a simple, free solutionThe secret to improving your credit rating is simple and free.First, pay your bills on time. Next, report discrepancies to thecredit bureau, reduce the amount you owe and close unused linesof credit.And remember to get a copy of your credit report at least once ayear. You can do so by contacting the three national creditbureaus: Equifax, 1-800-685-1111; Experian, 1-888-397-3742; andTransunion, 1-800-916-8800.In some states, including Georgia, you can request two freereports a year from each bureau.
WASHINGTON — Iowa Senator Chuck Grassley says “this day is years in the making” as the Senate Finance Committee which he chairs will take up the U.S. Mexico-Canada Agreement today.“This is good news for millions of farmers, manufacturers and workers in every corner of America,” Grassley says. “I expect USMCA to receive near-unanimous support both in my committee today and when the full Senate votes very soon.”Exactly how soon is the big question, however, as Senate Leader Mitch McConnell will have to schedule the USMCA vote around what Grassley calls the “very wild card” of the impeachment of President Trump. “He’s impeded in saying exactly when that can happen,” Grassley says, “because the minute that Speaker Pelosi decides to send over the articles of impeachment, if she decides to do that, then that’s going to have priority over everything else in the United States Senate.”In his decades in office, Grassley says he’s worked on at least 20 major trade agreements, but USMCA is unique. “This is the first treaty agreement that I’ve been involved in where we didn’t have what’s called a ‘markup’ before the treaty actually came up here,” Grassley says. “Once the treaty comes up here, it can’t be amended.”The agreement needs to pass both chambers of Congress. The House ratified USMCA in December, the same week it passed the two articles of impeachment.
Which one was more more mind stopping is a question of serious debate. The second one though was unbelievable. Cranes were trailing, legs were tired, fatigue had set in.He picked a ball, sidestepped once, dummied, then span – in full flight – to beat an army of Kenyan adversaries. He’s got height advantage, so he didn’t even get to the touchline; he simply stretched his arm as the last man managed to get his legs, and touched down! Incredible stuff!Against Namibia at home, he was a tale. Reports indicate they still talk about him. His first try: he kicked high up, chased and caught the ball, and sprinted to the touchline. Namibians were so awed they just looked on as he charged for a try.The second one he intercepted a pass, ‘danced’ around and bust for the touchline. It’s like Namibia had already given up on him.Wokos is a tag rugby graduate; he’s been to the UK for an invitational rugby development stint. He’s one of the most successful tag rugby trust graduates world over.His fetes are incredible; he’s already had two horrific injuries in his young career. His right femur snapped during a league game with then G4S Pirates. The second injury was in the UK during a rugby development stint with Esher Rugby Club. But not even those setbacks will stop him.Share on: WhatsApp Kenya Simbas and Rugby Cranes during a scrum Saturday evening at RFUEA grounds in Nairobi. Photo via @ntvugandaThat he was named man of the match on such a charged evening of rugby is no simple fete. In all honesty, Rugby Cranes fullback Phillip Wokorach left fans, Ugandans and Kenyans alike, bedazzled!These are things you see in NBA championships; but the lanky 24-year old displays in rugby. He is lithe, like a snake; he doesn’t just sidestep: he weaves, dances, and sprints. One of the commentators described him as “breaking tackles like knife through butter”.You wouldn’t even tell he’s broken a tackle, because it’s like he’s never challenged! It’s a wonder he’s debuted for the Cranes: he should have been here already, but for horrific injuries and long spells of recovery.Kenya beat uganda 45-24, but on the evening he made two tries; the first left the RFUEA fully packed stadium in awe, the second in disbelief!Kudos Uganda cranes for a good game. @WokorachPhillip‘s talent is undeniable. See you next time! #ElgonCup— Kenya Rugby 24/7 (@KenyaRugby247) July 30, 2016